- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01726153
A Pilot Trial of an Individualized Web-Based Condom Use Intervention
July 22, 2020 updated by: Centre hospitalier de l'Université de Montréal (CHUM)
A Pilot Randomized Control Trial (RCT) of an Individualized Condom-HIM Web-based Intervention for Condom USe Among HIV+ Gay Males
The purpose of this study is to evaluate the efficacy of an online intervention in increasing condom use among HIV+ gay males.
Study Overview
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 2K3
- Ryerson University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- are HIV-seropositive,
- Men who are having sex with men,
- engaging in unprotected anal intercourse with a partner who is serostatus negative or unknown
- age 18 years and older,
- ability to read English
- have access to a computer and internet.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Web sites
Individuals assigned to this arm are given a list of websites where they can view additional information relating to condom use.
|
|
|
EXPERIMENTAL: Condom-HIM
Individuals assigned to this arm must follow an on-line one session tailored intervention.
|
The tailored on-line Condom-HIM intervention is composed of a single session involving activities to increase individuals self-efficacy and intention to use condoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in participants self-efficacy in condom use at 2-weeks post-intervention
Time Frame: baseline and 2-weeks post intervention
|
The Self-Efficacy for condom use measure contains a set of items to rate participant's belief that they will be able to use condoms every time they have anal sex in a variety of situations.
A four-point response scale, ranging from 'strongly agree' (0) to 'strongly disagree' (4) is used.
The psychometric properties of the measure have been examined and have been shown to have good internal consistency with Cronbach's alpha coefficient of 0.96.
|
baseline and 2-weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in participants intention to use condoms at 2-weeks post-intervention
Time Frame: Baseline and 2-weeks post intervention
|
The intention to use condoms measure asks participants their intention to consistently use condoms.
The psychometric properties of the measure have been examined and have shown to have good internal consistency with Cronbach's alpha coefficient of 0.89.
|
Baseline and 2-weeks post intervention
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline in participants condom use at 2-weeks post-intervention Condom Use
Time Frame: baseline and 2-weeks post intervention
|
baseline and 2-weeks post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joyal Miranda, PhD, Ryerson University and Centre hospitalier de l'Universite de Montreal (CHUM)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (ACTUAL)
November 1, 2013
Study Completion (ACTUAL)
November 1, 2014
Study Registration Dates
First Submitted
November 6, 2012
First Submitted That Met QC Criteria
November 9, 2012
First Posted (ESTIMATE)
November 14, 2012
Study Record Updates
Last Update Posted (ACTUAL)
July 24, 2020
Last Update Submitted That Met QC Criteria
July 22, 2020
Last Verified
November 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- R0018767
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on Condom-HIM
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
-
Prof Mags BeksinskaCompletedFunctional PerformanceSouth Africa
-
Reckitt Benckiser Healthcare (UK) LimitedNovotech (Australia) Pty LimitedRecruiting
-
Ohio State UniversityUniversity of North Carolina, Chapel Hill; Ministry of Health, VietnamCompleted
-
Reckitt Benckiser Healthcare (UK) LimitedCompleted
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
-
Prof Mags BeksinskaCompletedPregnancy PreventionSouth Africa
-
University of Witwatersrand, South AfricaCompletedFunctional PerformanceSouth Africa
-
Okamoto Industries, Inc.NAMSATerminatedPerformance of Synthetic Polyurethane Male CondomUnited States
-
Karex Industries Sdn. Bhd.Essential Access Health; Match Research; Sigma3 Services SARLCompletedSexually Transmitted DiseasesUnited States, South Africa